Airway Medix S.A.

Osoba blisko związana z osobami pełniącymi obowiązki zarządcze: Anna Aranowska-Bablok - Członek Zarządu Adiuvo Investments S.A. oraz Prezes Zarządu Airwaymedix S.A.

Profile key: pl|airway medix s.a.

Purchase history

Companies traded: 1
Purchases · 12M: 1
Purchases · 24M: 1
Average purchase: PLN 2,626,805
Gross purchase value: PLN 2,626,805
Last purchase: 2026-06-30
Completed 20D events: 1.0
Outcome status: INSUFFICIENT_SAMPLE

Latest company: ADIUVO INVESTMENTS SPÓŁKA AKCYJNA W

Companies: ADIUVO INVESTMENTS SPÓŁKA AKCYJNA W

Post-purchase outcomes

Benchmark-relative outcomes are available against WIG20 total-return ETF proxy.

Excess return = stock return − WIG20 total-return ETF proxy return over the same period.
Hit rate = positive excess-return events ÷ completed events.
Price coverage = valid point-in-time prices ÷ events mature enough for that period.
Returns start on the first shared trading session on or after publication.

Period	Completed events	Price coverage	Hit rate	Median excess return	Average excess return	Worst excess return
5D	1Small sample	100.0% (1/1)	0.0% (0/1)	-1.4%	-1.4%	-1.4%
20D	1Small sample	100.0% (1/1)	100.0% (1/1)	+0.9%	+0.9%	+0.9%
60D	1Small sample	100.0% (1/1)	100.0% (1/1)	+33.4%	+33.4%	+33.4%
120D	0No data	Awaiting maturity	—	—	—	—

Research patterns

First purchase in 12M: Not classifiable
Large purchase ≥ €100k: 1/1
Cluster buying · 15D: 0/1
Buying the dip · ≥20% below prior 52W high: 1/1
Routine / opportunistic: Not classifiable

Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.

Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.